Anthem Biosciences
ANTHEM · Pharma > Pharmaceuticals & Drugs Listing date: July 21, 2025

Stock Price vs Company Growth
1d
1.6%
1w
10.6%
1m
11.8%
3m
3.5%
6m
14.9%
all
3.8%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 703 1.6%
579
705
Company Overview

Sales
2,011 Cr
Growth: 47.6%
Profit after Tax
526 Cr
Growth: -11.6%
Large Cap
39,483 Cr
P/E: 75.3x
Industry P/E: 29.7x
Fundamentals

Sales (Cr) ₹ 2,011
Growth 47.6%
EBITDA 36.1%
P/S 19.6x
Dividend 0.0%
P/E 75.3x
Book Value ₹ 2
PEG Ratio 1.6x
ROE 469.2%
P/B N/A
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

Anthem Biosciences has been set up as a Life sciences/ Biotechnology based venture specialising in the manufacture of catalytic preparation, other organic compounds such as speciality organic molecules, biologically active peptides etc., which are high-value products used in drug, agrochemical and speciality chemicals industries. Awards, accreditations, and recognition2023: Received a certificate of recognition as a ‘Four Star Export House’ from the Ministry of Commerce and Industry.
Followers (1)